| Authors: |
Shankar-Hari M; Centre for Critical Illness Research, Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London SE1 9RT, UK. Electronic address: manu.shankar-hari@kcl.ac.uk., Ming D; The Fleming Initiative, Imperial College London, London, UK., Mendelson M; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa., Rupali P; Department of Infectious Diseases, Christian Medical College, Vellore, India., Adhikari NKJ; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, and Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada., Ranzani O; DataHealth Lab, Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain., Randolph A; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, USA., Davenport E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., van der Poll T; Amsterdam UMC, University of Amsterdam, Center for Infection and Molecular Medicine & Division of Infectious Diseases, Amsterdam, Netherlands., Moita LF; Center for Disease Mechanisms Research, Medicine ULisboa for Health Clinical Research and Innovation (MUHCRI), Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal., Beane A; Pandemic Sciences Hub and Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, UK., Lamontagne F; Université de Sherbrooke, Sherbrooke, QC, Canada., Kwizera A; Makerere University College of Health Sciences, Kampala, Uganda., Holmes A; The Fleming Initiative, Imperial College London, London, UK., Diaz J; Clinical Management and Operations Unit, World Health Organization, Geneva, Switzerland. |
